Download PDFPDF
0099: Analysis of Gemcitabine As Second or Third Line Therapy for Recurrent Ovarian Cancer or Primary Peritoneal Cancer
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address